NSW Cannabis Medicines Prescribing Guidance

In 2018, ACRE received funding through NSW Government’s Clinical Cannabis Medicines Program to develop practical NSW Cannabis Medicines Prescribing Guidance to provide interim information to support NSW medical practitioners in prescribing cannabis medicines to patients for conditions where cannabinoids are perceived to have some benefit.

A suite of six (6) Prescribing Guidance documents have been developed, focused on the following indications:

The NSW Cannabis Medicines Prescribing Guidance are intended to give interim practical information to assist medical practitioners in their decision-making around prescribing and managing the use of cannabis medicines for NSW’s patients within current regulatory frameworks and clinical practice. Further, the NSW Cannabis Medicine Prescribing Guidance documents have been developed to align with the way that the use of new therapeutic products are communicated to prescribers.

WHO DEVELOPED THESE PRESCRIBING GUIDANCE DOCUMENTS?

Pharmacologists, pharmacists and clinicians from ACRE, the University of Newcastle Clinical Pharmacology Group and the NSW Cannabis Medicines Advisory Service (CMAS) were involved in the preparation and development of the initial Prescribing Guidance documents, including:

  • Professor Jennifer Martin
  • Dr Catherine Lucas
  • Associate Professor Jennifer Schneider
  • Dr Joanne Patel
  • Dr Jessica Ryan
  • Myfanwy Graham 

The Prescribing Guidance documents were also provide to the ACRE Clinical Advisory Group, comprised of relevant subject matter specialists, for review and feedback.

 

ACRE is sincerely committed to fostering collaborative relationships with all stakeholders, including patients, consumers and their representatives who have an interest in the therapeutic use of cannabis medicines. On this basis, the draft NSW Cannabis Medicine Prescribing Guidance documents were purposefully promulgated to over fifty individuals and stakeholders for input and feedback as part of a Stakeholder Consultation process in early 2019 to ensure that key stakeholders, including medical practitioners, pharmacists, and consumer advocacy groups, were also provided with an opportunity to inform these final documents.

The NSW Cannabis Medicines Prescribing Guidance are intended to be dynamic documents and will be reviewed and updated annually and/or as new evidence emerges.

FUNDING

NSW Government through the NSW Clinical Cannabis Medicines Program supported development of the NSW Cannabis Medicines Prescribing Guidance.

ACRE was establish and is funded through the National Health and Medical Research Council Centres of Research Excellence scheme.

FURTHER INFORMATION 

For further information on the NSW Cannabis Medicines Prescribing Guidance, email [email protected]  

DOWNLOAD HERE

 

Information for Health Professionals

NSW Cannabis Medicines Advisory Service

The NSW Cannabis Medicines Advisory Service provides expert clinical guidance and support to NSW doctors considering prescribing a cannabis medicine for their patient.

The Service is part of the NSW Government $21 million commitment to advance understanding for the safe and appropriate use of cannabis medicines to treat serious and debilitating symptoms.

The Service is available to NSW doctors and health care professionals. It is operational during normal office hours – Monday to Friday 9am to 5pm.

The Service can be contacted by email [email protected] or by telephone (02) 4923 6200.

The Service can assist with:

  • understanding the latest evidence around cannabis medicines
  • understanding the regulatory requirements for cannabis prescription
  • considering tools to monitor a patient’s progress whilst using cannabis medicines
  • provision of protocols to facilitate cannabis medicine prescribing
  • information about dosing and titration in individual patients

TGA Medicinal Cannabis Clinical Guidance Documents

The Therapeutic Goods Administration have produced a number of clinical guidance documents for prescribers of medicinal cannabis products in Australia. In addition to an overview of medicinal cannabis, available guidance includes using medicinal cannabis to treat chemotherapy-induced nausea and vomiting, epilepsy, multiple sclerosis, chronic non-cancer pain and palliative care.

Information for Patients

Accessing medicinal cannabis in Australia

Australian patients cannot arrange their own access to medicinal cannabis products. Only Australian registered medical practitioners with appropriate qualifications and/or expertise for the medical condition requiring treatment are able to arrange for access to medicinal cannabis on behalf of their patients. Approval or authorisation is granted by the Australian Therapeutic Goods Administration (TGA) and individual states on a case-by-case basis. For further information visit the TGA's Patient Information page.

WA Patient Access

For information on how to access cannabis-based medicines in Western Australia visit the Western Australian Government's HealthyWA Medicinal Cannabis page.

NT Patient Access

For information on how to access cannabis-based medicines in the Northern Territory visit the NT Government's Medicinal Cannabis page.

TAS Patient Access

For information on how to access cannabis-based medicines in Tasmania visit the Department of Health and Human Services Medicinal Cannabis page.

ACT Patient Access

For information on how to access cannabis-based medicines in the ACT visit the ACT Health Medical Cannabis page.

NSW Patient Access

For information on how to access cannabis-based medicines in NSW and current NSW-based clinical trials visit the NSW Centre for Medicinal Cannabis Research and Innovation.

VIC Patient Access

For information on how to access cannabis-based medicines in Victoria visit the Office of Medicinal Cannabis.

QLD Patient Access

For information on how to access cannabis-based medicines in Queensland visit the Queensland Government's Medicinal Cannabis page.

SA Patient Access

For information on how to access cannabis-based medicines in South Australia visit SA Health's Medicinal Cannabis page.

ACRE • All Right Reserved

Website by mudbath